These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19097407)

  • 1. [Comparison of three chemiluminescent methods with a radioimmunoassay for thyroglobulin measurement in the follow-up of differentiated thyroid cancer].
    Sylla NM; Bombled C; Schlumberger M; Bidart JM
    Dakar Med; 2007; 52(3):225-30. PubMed ID: 19097407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of an immunoassay for calcitonin].
    Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
    Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
    Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
    Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay.
    Gao Y; Yuan Z; Yu Y; Lu H
    Clin Biochem; 2007 Jun; 40(9-10):735-8. PubMed ID: 17462616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
    Aras G; Gültekin SS; Küçük NO
    Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
    Spencer CA; Lopresti JS
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
    Iervasi A; Iervasi G; Carpi A; Zucchelli GC
    Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.
    Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR
    Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and performance goals for serum thyroglobulin assays.
    Spencer CA; Takeuchi M; Kazarosyan M
    Clin Chem; 1996 Jan; 42(1):164-73. PubMed ID: 8565221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of thyroglobulin in the circulation: clinical and technical considerations.
    Schneider AB; Ikekubo K
    Ann Clin Lab Sci; 1979; 9(3):230-5. PubMed ID: 464541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance between thyroglobulin antibody assays.
    Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continously increasing sensitivity in thyroid cancer aftercare in the course of three generations of thyroglobulin IMAs].
    Görges R; Brandt-Mainz K; Freudenberg L; Frilling A; Grimm W; Bockisch A
    Nuklearmedizin; 2003 Aug; 42(4):157-66. PubMed ID: 12937694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of discordance between thyroglobulin antibody assays.
    Pickett AJ; Jones M; Evans C
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):463-7. PubMed ID: 22829697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
    Wong J; Lu Z; Doery J; Fuller P
    Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the first automated thyroglobulin assay.
    Vogeser M; Knesewitsch P; Jacob K; Seidel D
    Clin Chem Lab Med; 1999 Feb; 37(2):159-64. PubMed ID: 10219505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring.
    Krahn J; Dembinski T
    Clin Biochem; 2009 Mar; 42(4-5):416-9. PubMed ID: 19154731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ultra-sensitive soybean peroxidase-based CL-ELISA for the determination of human thyroglobulin.
    Vdovenko MM; Zubkov AV; Kuznetsova GI; Ciana LD; Kuzmina NS; Sakharov IY
    J Immunol Methods; 2010 Oct; 362(1-2):127-30. PubMed ID: 20851124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid.
    Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Kameko F; Tajiri J; Kato R
    Clin Chim Acta; 2007 Apr; 379(1-2):101-4. PubMed ID: 17270168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.